| Schedule of Segment Reporting Information, by Segment [Table Text Block] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
2022 |
|
2021 |
|
2020 |
Net sales: |
|
|
|
|
|
|
|
|
Protein Sciences |
$ |
832,311 |
|
$ |
704,564 |
|
$ |
555,352 |
Diagnostics and Genomics |
|
274,843 |
|
|
227,744 |
|
|
184,549 |
Intersegment |
|
(1,555) |
|
|
(1,276) |
|
|
(1,210) |
Consolidated net sales |
$ |
1,105,599 |
|
$ |
931,032 |
|
$ |
738,691 |
|
|
|
|
|
|
|
|
|
Operating income: |
|
|
|
|
|
|
|
|
Protein Sciences(1) |
$ |
377,623 |
|
$ |
330,225 |
|
$ |
234,929 |
Diagnostics and Genomics |
|
48,977 |
|
|
38,425 |
|
|
14,965 |
Segment operating income |
|
426,600 |
|
|
368,650 |
|
|
249,894 |
Costs recognized on sale of acquired inventory |
|
(1,596) |
|
|
(1,565) |
|
|
— |
Amortization of acquisition related intangible assets |
|
(73,054) |
|
|
(64,239) |
|
|
(60,865) |
Impact of partially owned consolidated subsidiaries(1) |
|
(2,393) |
|
|
(1,505) |
|
|
— |
Gain on escrow settlement |
|
— |
|
|
— |
|
|
7,169 |
Acquisition related expenses |
|
19,070 |
|
|
(7,114) |
|
|
(416) |
Eminence impairment |
|
(18,715) |
|
|
— |
|
|
— |
Stock based compensation, inclusive of employer taxes |
|
(46,401) |
|
|
(51,846) |
|
|
(34,262) |
Restructuring costs |
|
(1,640) |
|
|
(142) |
|
|
(87) |
Corporate general, selling, and administrative expenses(1) |
|
(5,281) |
|
|
(4,943) |
|
|
(4,015) |
Consolidated operating income |
$ |
296,590 |
|
$ |
237,296 |
|
$ |
157,419 |
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
2022 |
|
2021 |
|
2020 |
Consumables revenue - Protein Sciences |
|
$ |
646,952 |
|
$ |
557,037 |
|
$ |
431,052 |
Consumables revenue - Diagnostics and Genomics |
|
|
243,922 |
|
|
194,948 |
|
|
171,590 |
Total consumable revenue |
|
$ |
890,874 |
|
$ |
751,985 |
|
$ |
602,642 |
|
|
|
|
|
|
|
|
|
Year ended June 30, |
|
|
2022 |
|
2021 |
Long-lived assets: |
|
|
|
|
|
|
United States and Canada |
|
$ |
203,732 |
|
$ |
190,501 |
Europe |
|
|
16,223 |
|
|
13,949 |
Asia |
|
|
3,287 |
|
|
3,457 |
Total long-lived assets |
|
$ |
223,242 |
|
$ |
207,907 |
Intangible assets: |
|
|
|
|
|
|
United States and Canada |
|
$ |
523,536 |
|
$ |
594,512 |
Europe |
|
|
6,281 |
|
|
9,369 |
Asia |
|
|
1,705 |
|
|
12,087 |
Total intangible assets |
|
$ |
531,522 |
|
$ |
615,968 |
|